Sreelakshmi24’s Blog

where life is all about learning

Posts Tagged ‘Piramal Healthcare

Piramal Healthcare Launches Supractiv Complete – A Total Nutritional Supplement

with 68 comments

The nutritional supplement market is the largest segment in the OTC market accounting for over 45% of the OTC products in India. In fact this segment has witnessed a rapid rise in the last few years and is growing at a healthy growth rate of about 12%.


Piramal Healthcare Limited, one of India’s largest integrated healthcare companies launched Supractiv Complete – a total nutritional supplement. Supractiv Complete is rich in many nutrients such as Glutamine, Zinc, Vitamin B-Complex, Vitamins C, Vitamin E, Ginseng, Calcium, Amino Acids and Antioxidants.

Supractiv Complete works on supporting the whole body for nutrition rather than providing only a select benefit, like energy or immunity. Supractiv Complete not only has the right ingredients but also has them in optimal quantities. Its formulation has been prepared by taking into consideration the Recommended Daily Allowance suggested by the Indian Council of Medical Research. One Supractiv Complete a day has nutrients that will provide mental agility, immunity, heart health, stamina, vitality and muscle & bone strength.

A consumer trial conducted by Piramal Healthcare in accordance with a renowned research agency amongst 900 respondents showed that over 98% of them felt a positive discernible difference with Supractiv Complete in just 6 days.

Highlighting the need for a complete nutritional supplement in India, Dr. Swati Piramal, Director, Piramal Healthcare Ltd., said, “Our dietary habits have changed drastically over the years, thanks increasingly to our changing lifestyles. This has rendered our everyday diet deficient in vital nutrients. Hence, there is a pronounced need for nutritional supplement in Indians. At Piramal Healthcare, we believe in reducing the burden of disease and fostering healthy lives. Propelled by our core values of Knowledge Action Care, we continuously strive to apply breakthrough innovations to provide quality products to our end customers. The idea behind launching Supractiv Complete was to empower the consumers to make an informed choice about their nutritional supplements.”

Supractiv Complete is available in a uniquely designed packaged jar of 30 and a convenient trial pack of 10. The clutter breaking packaging not only serves to attract the consumer but also works towards explaining the product, its attributes and the manner in which it works on the human body. Priced between Rs. 60 & 180, Supractiv Complete will be available shortly at chemists’ stores across India.

Written by sreelakshmi

27 May, 2009 at 10:52 pm

Piramal Healthcare launches ActiPatch™ in India

leave a comment »

One of 9 Medical Breakthroughs That May Change Your Life”

 

According to the American Chronic Pain Association, pain is the number one cause of adult disability. The Indian Pain Management market is valued at Rs. 3000 crore with around 1.5 lakh patients on some form of pain management therapy every day.

Piramal Healthcare Limited, one of India’s largest integrated healthcare companies’ launched BioElectronic’s ActiPatch™, a revolutionary product in pain management. ActiPatch™ has recently been chosen as ‘One of 9 Medical Breakthroughs That May Change Your Life’, by MedicalHeadway.com in the USA and is fast becoming the treatment of choice for everything from soft tissue injuries to surgical recovery.

ActiPatch™ is a medical device that utilizes Pulsed Electro-Magnetic Frequency (PEMF) to accelerate healing of soft tissue injuries. A drug-free patch with an embedded battery operated microchip; ActiPatch™ delivers weeks of continuous pulsed therapy. Patients suffering from pain and swelling in conditions such as, low back pain, sports and work injuries, ankle sprain, tennis elbow, all kinds of sprains & strains and inflammation can benefit from this product. Its unique delivery system, using patented technology, provides a cost-effective patient friendly method to reduce soft tissue pain & swelling.

ActiPatch™ is available in four different ranges; for back pain therapy, knee pain therapy, foot & ankle pain therapy, and for wrist pain therapy. The ActiPatch™ range for back pain & knee pain therapy works for maximum 720 hours (30 days) and that of foot & ankle and the wrist pain therapy has a working time of 360 hours (15 days). Worldwide, ActiPatch™ is available as an OTC product. However in India, ActiPatch™ will be available only by prescription.

Dr. Swati Piramal,
Director, Piramal Healthcare Ltd., said, “At Piramal Healthcare we believe in reducing the burden of disease. Propelled by our core values of Knowledge Action Care, Piramal Healthcare strives to apply breakthrough technology and continuously explore innovations to alleviate the lives of the end patients. With the ActiPatch™ launch, we are delighted to bring yet another advanced product to India to offer a cost effective healing solution.”


Andrew J. Whelan, CEO of BioElectronics Corporation, explains, “We congratulate Piramal Healthcare on bringing this important technology to India. With its strong infrastructure, Piramal Healthcare is a right partner to help us roll our product in India. We look forward to working with Piramal to make this revolutionary product a success in the Indian market.”

Written by sreelakshmi

22 May, 2009 at 7:22 am

Piramal Healthcare honours the best interventional cardiologists in India

with 2 comments

Piramal Healthcare Limited, one of India’s largest pharmaceutical companies, awarded the ‘Piramal Knowledge Academy Best Intervention Award 2009‘ to four eminent interventional cardiologists at the National Intervention Council (NIC) on April 26, 2009 in Hyderabad. Around 500 interventional cardiologists attended the program. Dr. Sarat Chandra, Chairman, National Intervention Council was instrumental in integrating this award in NIC. He presided over the conference and headed the jury that chose the winners.

Piramal Knowledge Academy supports the cause of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Registry and is aimed at promoting unique Percutaneous Coronary Intervention (PCI) by interventional cardiologists. PTCA Registry is a mid-term scientific fiesta which is organised every year, where more than 100 pre-selected cases are shown and discussed for everyone’s benefit over the course of the three days of the Registry. Piramal Knowledge Academy will continue to honour and acknowledge the best angioplasty cases in the country every year.

Piramal Knowledge Academy conducts a host of Advisory Panel Programmes, Skill Upgradation Programmes and Collaborative Educational Programmes with the medical fraternity. Dr. Swati Piramal, Director Communications & Strategic Alliances, Piramal Healthcare Limited said, “Piramal Knowledge Academy was conceptualized with the belief that sharing of knowledge with the medical fraternity is an imperative to alleviate the lives of the end patients and thereby the status of healthcare in India. It is our humble attempt at recognizing and felicitating stellar achievements in interventional cardiology.”

The winners of the prestigious award this year are:

  • Dr. Navneet Singh from AIIMS, Delhi for his unusual case of CoArc dilatation,
  • Dr. Bhanu from J.J. Medical College, Mumbai for her case on ballooning and stenting in peripheral and pulmonary artery stenosis,
  • Dr. Pankaj Jariwalla from Nizam’s Institute of Medical Sciences, Hyderabad for his case on left systemic artery to pulmonary vein AV valve formation, closed by vascular plug & coil embolisation and
  • Dr. Harikrishna from Shri Chitra Institute of Medical Sciences, Trivandrum for Ductal stenting in a neonate. The winners were honoured with a monetary award of Rs. 20,000, a certificate and an annual print subscription to an international health journal of repute.

The medical fraternity unreservedly appreciated this initiative from Piramal Healthcare. “It is a great honour for me to receive this award,” said Dr. Harikrishnan.

Mumbai High Court Order Against Firms Selling Counterfeits of Piramal Healthcare’s Esgipyrin

with one comment

Piramal Healthcare Ltd. obtained a common ex-parte ad-interim order from the Mumbai High Court on Thursday, April 9, 2009 restraining four companies from using trademarks similar to its product Esgipyrin. Piramal Healthcare is a registered proprietor of the mark ‘Esgipyrin’ and the company has been using the trademark since 1974.

The four companies that have been restrained via this order are:

  • Endolabs Healthcare Pvt. Ltd., for their trademark Easipyrin
  • Endolabs Lifescience, for their trademark Elgipyrin
  • Spachem Laboratories Pvt. Ltd., for their trademark Zypyrine
  • Endolabs Ltd., for their trademark Agepyrine

The order states that the companies have introduced the infringing products for the same ailment as countered by Piramal’s Esgipyrin and that it has been prima facie seen that the product is deceptively similar to that of the original product. The order further goes on to state that the companies have been engaged in a deliberate, dishonest and fraudulent act of counterfeiting and are passing off their products as that from Piramal Healthcare.

A counterfeit drug is a medication or pharmaceutical product which is produced and sold with the intent to deceptively represent its origin, authenticity or effectiveness. The prevalence of counterfeit drugs appears constantly to be on the rise and these drugs are a major cause of morbidity, mortality, and loss of public confidence in medicines, the manufacturers and the overall health structures.

Written by sreelakshmi

15 April, 2009 at 5:38 pm

Nandini Piramal joins Piramal Healthcare as the Executive Director

leave a comment »

Piramal Healthcare Limited has announced the appointment of Ms. Nandini Piramal on the Board of the company as the Executive Director. Nandini Piramal has been associated with the business for last four years looking after the operations in Canada. Nandini Piramal is the daughter of the promoters Mr. Ajay Piramal and Dr. Swati Piramal.

Prior to her induction on the Board of Piramal Group, Nandini Piramal was the GM – Strategic Marketing of Piramal Healthcare, during which she was closely associated with the business of the company’s overseas subsidiaries and gained deep insight into the Group’s Pharma Solutions business. She played a key role in implementation of Operational Excellence Projects at the company’s overseas locations in UK and Canada. She was also actively involved in due diligence of acquisition and joint venture targets.

Ms. Piramal is a graduate in BA (Hons.) from Hertford College, Oxford University and is an MBA from the Stanford Graduate School of Business. In her role as a Business Analyst with a leading management consulting firm she worked on projects in Growth Strategy, Supply Chain Management and Information Technology Strategy of various corporate clients.


Mr. Ajay Piramal is the India Innovator of the Year

leave a comment »

Mr. Ajay Piramal, Chaiman, Piramal Healthcare was adjudged as the India Innovator Of The Year at the CNBC-TV18 India Business Leader Awards presented by Accenture. The award ceremony saw the best in Indian Business come together to salute the finest in Corporate India. Held in Mumbai the awards were graced by the presence of Shri. Kamal Nath, Union Minister of Commerce and Industries, Shri. Ashok Chavan, Chief Minister, Maharashtra, Shri.
Narendra Modi, Chief Minister, Gujarat among others who felicitated the winners.

While accepting the honour, Mr. Piramal said that the task before us is immense. He also hoped that India would be able to invent a drug, a feat that still eludes the country.

The 4th CNBC-TV18 India Business Leader Awards, India’s most definitive awards in business excellence, felicitated the visionaries who have set shining examples in business leadership over the years. The winners were judged by business leaders
like Mr. Mukesh Ambani, Reliance Industries Ltd. (Chairperson, Jury), Mr. Kumar Mangalam Birla, Chairman, Aditya Birla Group, Mr. Deepak Parekh, Chairman, HDFC, Mr. R. Seshasayee, Managing Director, Ashok Leyland, Mr. Jagdish Khattar, CMD, Carnation Auto India Pvt. Ltd. and Mr.
Raghav Bahl, MD, Network18.

Talking on the parameters on which the winners were selected, Mr. Ambani said, “A leader has to navigate the path and protect the interests of all the stakeholders in a consistent way so that they can deliver performance on an ongoing basis. Also Execution and accomplishments were the main considerations.” According to Mr. Birla, track record is important. Long term viability and sustainability of the business model is also vital. Mr Parekh believes that individual contribution to the company is very important especially in troubled times like these.

Speaking about the awards, Mr. Ajay Chacko, Director, TV18, Business Media said, “India Business Leader Awards are an unparalleled tribute to the excellence in business in India. The awards have become in institution by itself and the winners epitomize strength, ingenuity, knowledge, foresight and who drive the growth of their businesses with vision and inspiration.”